BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16621625)

  • 1. Mitochondrial targeting of human protoporphyrinogen oxidase.
    Davids LM; Corrigall AV; Meissner PN
    Cell Biol Int; 2006 May; 30(5):416-26. PubMed ID: 16621625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of sequences required for the import of human protoporphyrinogen oxidase to mitochondria.
    Morgan RR; Errington R; Elder GH
    Biochem J; 2004 Jan; 377(Pt 2):281-7. PubMed ID: 14535846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel human pathological mutations. Gene symbol: PPOX. Disease: porphyria, variegate.
    Ausenda S; Moriondo V; Marchini S; Besana V; Di Pierro E; Brancaleoni V; Ventura P; Rocchi E; Cappellini MD
    Hum Genet; 2009 Apr; 125(3):344. PubMed ID: 19320019
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification and characterisation of a deletion (537delAT) in the protoporphyrinogen oxidase gene in a South African variegate porphyria family.
    Corrigall AV; Hift RJ; Hancock V; Meissner D; Davids L; Kirsch RE; Meissner PN
    Hum Mutat; 1998; 12(6):403-7. PubMed ID: 9829909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel human pathological mutations. Gene symbol: PPOX. Disease: porphyria, variegate.
    Ausenda S; Di Pierro E; Brancaleoni V; Besana V; Cappellini MD
    Hum Genet; 2007 Nov; 122(3-4):417. PubMed ID: 18350656
    [No Abstract]   [Full Text] [Related]  

  • 6. Extended haplotype studies in South African and Dutch variegate porphyria families carrying the recurrent p.R59W mutation confirm a common ancestry.
    van Tuyll van Serooskerken AM; Drögemöller BI; Te Velde K; Bladergroen RS; Steijlen PM; Poblete-Gutiérrez P; van Geel M; van Heerden CJ; Warnich L; Frank J
    Br J Dermatol; 2012 Feb; 166(2):261-5. PubMed ID: 21910705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene symbol: PPOX. Disease: Porphyria, variegate.
    Ausenda S; Di Pierro E; Besana V; Brancaleoni V; Cappellini MD
    Hum Genet; 2008 Feb; 123(1):109. PubMed ID: 18386343
    [No Abstract]   [Full Text] [Related]  

  • 8. A recurrent mutation in variegate porphyria patients from Chile and Sweden: Evidence for a common genetic background?
    van Serooskerken AM; Ernst M; Bladergroen RS; Wolff C; Floderus Y; Harper P; Poblete-Gutiérrez P; van Geel M; Frank J
    J Dermatol Sci; 2011 Jan; 61(1):75-7. PubMed ID: 21111578
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural insight into human variegate porphyria disease.
    Qin X; Tan Y; Wang L; Wang Z; Wang B; Wen X; Yang G; Xi Z; Shen Y
    FASEB J; 2011 Feb; 25(2):653-64. PubMed ID: 21048046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous manifestation of variegate porphyria in monozygotic twins.
    Borradori L; Van Tuyll van Serooskerken AM; Abraham S; Hohl D; Schneider-Yin X; Minder E; Frank J
    Br J Dermatol; 2008 Aug; 159(2):503-5. PubMed ID: 18544078
    [No Abstract]   [Full Text] [Related]  

  • 11. [Identification of mutations in the protoporphyrin oxidase gene and its diagnostic implications in porphyria variegata in Chile].
    Wolff C; Frank J; Poblete-Gutiérrez P
    Rev Invest Clin; 2006; 58(4):289-95. PubMed ID: 17146940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane synthase is associated with liver cancer in acute porphyrias.
    Schneider-Yin X; van Tuyll van Serooskerken AM; Siegesmund M; Went P; Barman-Aksözen J; Bladergroen RS; Komminoth P; Cloots RH; Winnepenninckx VJ; zur Hausen A; Weber M; Driessen A; Poblete-Gutiérrez P; Bauer P; Schroeder C; van Geel M; Minder EI; Frank J
    J Hepatol; 2015 Mar; 62(3):734-8. PubMed ID: 25445397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variegate porphyria in a 46-year-old patient taking sibutramine for weight loss.
    Reiser M; Eickmann S; Haverkamp T; Finckh U
    Obes Rev; 2010 Apr; 11(4):329-31. PubMed ID: 19845869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the first variegate porphyria mutation in an indigenous black South African and further evidence for heterogeneity in variegate porphyria.
    Corrigall AV; Hift RJ; Davids LM; Hancock V; Meissner D; Kirsch RE; Meissner PN
    Mol Genet Metab; 2001 May; 73(1):91-6. PubMed ID: 11350188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracing an old journey in variegate porphyria.
    Badminton MN
    Br J Dermatol; 2012 Feb; 166(2):237. PubMed ID: 22268855
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative structural insight into human variegate porphyria disease.
    Wang B; Wen X; Qin X; Wang Z; Tan Y; Shen Y; Xi Z
    J Biol Chem; 2013 Apr; 288(17):11731-40. PubMed ID: 23467411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overrepresentation of the founder PPOX gene mutation R59W in a South African patient with severe clinical manifestation of porphyria.
    de Villiers JN; Kotze MJ; van Heerden CJ; Sadie A; Gardner HF; Liebenberg J; van Zyl R; du Plessis L; Kimberg M; Frank J; Warnich L
    Exp Dermatol; 2005 Jan; 14(1):50-5. PubMed ID: 15660919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variegate porphyria.
    Kirsch RE; Meissner PN; Hift RJ
    Semin Liver Dis; 1998; 18(1):33-41. PubMed ID: 9516676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic study of the clinical and biochemical expression of variegate porphyria in a large South African family.
    Hift RJ; Meissner D; Meissner PN
    Br J Dermatol; 2004 Aug; 151(2):465-71. PubMed ID: 15327556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma in variegate porphyria: a serious complication.
    Schneider-Yin X; van Tuyll van Serooskerken AM; Went P; Tyblewski W; Poblete-Gutiérrez P; Minder EI; Frank J
    Acta Derm Venereol; 2010 Sep; 90(5):512-5. PubMed ID: 20814629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.